Iga nephropathy Trials in Beijing, China
Conditions / Iga nephropathy / Beijing, China
Research into Iga nephropathy spans multiple therapeutic approaches and trial phases.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04578834 | Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients | COMPLETED | PHASE3 |
| NCT05775042 | Clinical Study of CM338 in the Treatment of Immunoglobulin A Nephropathy | RECRUITING | PHASE2 |
| NCT06830395 | Study of CM313 in Subject With IgA Nephropathy | NOT_YET_RECRUITING | PHASE2 |
| NCT06774664 | A Clinical Study of SCTC21C in Participants With Plasma Cell-driven Autoimmune Diseases | NOT_YET_RECRUITING | PHASE1/PHASE2 |
| NCT02231125 | Efficacy and Safety of Abelmoschus Manihot for IgA Nephropathy | UNKNOWN | PHASE4 |
| NCT05434325 | TESTING -ON Post-Trial ObservatioNal Cohort Study | RECRUITING | — |
| NCT04573478 | Atrasentan in Patients With IgA Nephropathy | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03373461 | Study of Safety and Efficacy of LNP023 in Patients With Kidney Disease Caused by Inflammation | COMPLETED | PHASE2 |
| NCT05852938 | A Study of Zigakibart in Adults With IgA Nephropathy | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03015974 | Registry of IgA Nephropathy in Chinese Children | UNKNOWN | — |